Fisher Scientific and Thermo Electron recently received a second request for additional information from the Federal Trade Commission (FTC) regarding the upcoming merger of the two companies.

“In response to a second request for information from the FTC, Fisher is planning to divest its $17 million solvent evaporation systems (vacuum concentrators) product line,” according to Lori Gorski, a spokesperson for Thermo Electron. “We will continue to work with the various regulatory bodies, including the EC and FTC, and still anticipate a Q4 closing.”

Previous articleApplied Biosystems Launches Software Development Community
Next articleGSK Inks Drug Discovery Deal with ChemoCentryx